Literature DB >> 24028150

Emodin inhibits ATP-induced IL-1β secretion, ROS production and phagocytosis attenuation in rat peritoneal macrophages via antagonizing P2X₇ receptor.

Shuyan Zhu1, Yuxiang Wang, Xinyu Wang, Junying Li, Fen Hu.   

Abstract

CONTEXT: Previous in vitro studies have demonstrated that emodin (1,3,8-trihydroxy-6-methyl-anthraquinone), an anthraquinone derivative from the rhizome of Rheum palmatum L., can inhibit the activation of P2X₇ receptors (P2X₇R) as a potential antagonist. However, the effects of emodin on P2X₇R-related inflammatory processes remain unclear.
OBJECTIVE: This study aimed to investigate the effects of emodin on different inflammation responses of macrophages induced by ATP, the natural ligand of P2X₇R.
MATERIALS AND METHODS: Rat peritoneal macrophages were treated with millimolar ATP and emodin (0.1, 0.3, 1, 3, 10 µM) or brilliant blue G (BBG, 0.1, 1, 10 µM). Cytosolic Ca²⁺ concentration ([Ca²⁺]c) was detected by fluorescent Ca²⁺ imaging. Interleukin-1β (IL-1β) release was measured by rat IL-1β ELISA kits. Reactive oxygen species (ROS) generation was examined by dihydroethidium (DHE) fluorescent staining. Phagocytic activity was tested by neutral red uptake assay.
RESULTS: We found that the [Ca²⁺](c) increase evoked by ATP (5 mM) was inhibited by emodin, in a dose-dependent manner with IC₅₀ of 0.5 μM. Furthermore, emodin reduced the IL-1β release induced by ATP (2 mM) in lipopolysaccharide (LPS)-activated macrophages, with an IC₅₀ of 1.6 μM. Emodin also strongly suppressed the ROS production and phagocytosis attenuation triggered by ATP (1 mM), with IC₅₀ values of 1 μM and 0.7 μM, respectively. Besides, BBG, a specific antagonist of P2X₇R, exhibited similar suppressive effects on these inflammation responses.
CONCLUSION: These results showed the inhibitory effects of emodin on ATP-induced [Ca²⁺](c) increase, IL-1β release, ROS production and phagocytosis attenuation in rat peritoneal macrophages, by inhibiting the activation of P2X₇R.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24028150     DOI: 10.3109/13880209.2013.810648

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  18 in total

Review 1.  Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

Review 2.  Effects of Anthraquinones on Immune Responses and Inflammatory Diseases.

Authors:  Dandan Xin; Huhu Li; Shiyue Zhou; Hao Zhong; Weiling Pu
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

3.  Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages.

Authors:  Stephen Iwanowycz; Junfeng Wang; Johnie Hodge; Yuzhen Wang; Fang Yu; Daping Fan
Journal:  Mol Cancer Ther       Date:  2016-05-18       Impact factor: 6.261

Review 4.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

Review 5.  Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin.

Authors:  Esra Küpeli Akkol; Iffet Irem Tatlı; Gökçe Şeker Karatoprak; Osman Tuncay Ağar; Çiğdem Yücel; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

Review 6.  Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.

Authors:  Xiaopeng Ai; Xing Dong; Ying Guo; Peng Yang; Ya Hou; Jinrong Bai; Sanyin Zhang; Xiaobo Wang
Journal:  Purinergic Signal       Date:  2021-03-22       Impact factor: 3.765

7.  Rhein antagonizes P2X7 receptor in rat peritoneal macrophages.

Authors:  Fen Hu; Fulin Xing; Ge Zhu; Guangxue Xu; Cunbo Li; Junle Qu; Imshik Lee; Leiting Pan
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

8.  Systemic blockade of P2X7 receptor protects against sepsis-induced intestinal barrier disruption.

Authors:  Xiuwen Wu; Jianan Ren; Guopu Chen; Lei Wu; Xian Song; Guanwei Li; Youming Deng; Gefei Wang; Guosheng Gu; Jieshou Li
Journal:  Sci Rep       Date:  2017-06-29       Impact factor: 4.379

9.  Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.

Authors:  Victor H Leyva-Grado; Megan E Ermler; Michael Schotsaert; Ma G Gonzalez; Virginia Gillespie; Jean K Lim; Adolfo García-Sastre
Journal:  MBio       Date:  2017-03-28       Impact factor: 7.867

Review 10.  Phytoceuticals in Acute Pancreatitis: Targeting the Balance between Apoptosis and Necrosis.

Authors:  Laura Gaman; Dorin Dragos; Adelina Vlad; Georgiana Catalina Robu; Mugurel Petrinel Radoi; Laura Stroica; Mihaela Badea; Marilena Gilca
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.